Fidelity Investments’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.19M | Sell |
164,271
-277,269
| -63% | -$3.7M | ﹤0.01% | 2457 |
|
|
2025
Q1 | $4.5M | Sell |
441,540
-5,101,768
| -92% | -$52M | ﹤0.01% | 2186 |
|
|
2024
Q4 | $87.8M | Buy |
5,543,308
+644,174
| +13% | +$10.2M | 0.01% | 1172 |
|
|
2024
Q3 | $284M | Buy |
4,899,134
+179,374
| +4% | +$10.4M | 0.02% | 688 |
|
|
2024
Q2 | $216M | Sell |
4,719,760
-298,756
| -6% | -$13.7M | 0.01% | 758 |
|
|
2024
Q1 | $332M | Buy |
5,018,516
+1,144,312
| +30% | +$75.8M | 0.02% | 590 |
|
|
2023
Q4 | $154M | Buy |
3,874,204
+269,276
| +7% | +$10.7M | 0.01% | 851 |
|
|
2023
Q3 | $115M | Sell |
3,604,928
-454,113
| -11% | -$14.5M | 0.01% | 912 |
|
|
2023
Q2 | $163M | Buy |
4,059,041
+7,168
| +0.2% | +$288K | 0.01% | 804 |
|
|
2023
Q1 | $173M | Buy |
4,051,873
+372,784
| +10% | +$15.9M | 0.02% | 766 |
|
|
2022
Q4 | $177M | Sell |
3,679,089
-184,437
| -5% | -$8.86M | 0.02% | 737 |
|
|
2022
Q3 | $145M | Buy |
3,863,526
+263,631
| +7% | +$9.92M | 0.02% | 806 |
|
|
2022
Q2 | $99.5M | Buy |
3,599,895
+591,959
| +20% | +$16.4M | 0.01% | 974 |
|
|
2022
Q1 | $164M | Sell |
3,007,936
-496,862
| -14% | -$27M | 0.01% | 861 |
|
|
2021
Q4 | $205M | Buy |
3,504,798
+4,119
| +0.1% | +$241K | 0.02% | 798 |
|
|
2021
Q3 | $138M | Buy |
3,500,679
+6,140
| +0.2% | +$243K | 0.01% | 969 |
|
|
2021
Q2 | $148M | Buy |
3,494,539
+566,422
| +19% | +$24.1M | 0.01% | 938 |
|
|
2021
Q1 | $180M | Buy |
2,928,117
+283,497
| +11% | +$17.4M | 0.02% | 827 |
|
|
2020
Q4 | $187M | Buy |
2,644,620
+856,075
| +48% | +$60.4M | 0.02% | 772 |
|
|
2020
Q3 | $69M | Buy |
1,788,545
+428,873
| +32% | +$16.5M | 0.01% | 1079 |
|
|
2020
Q2 | $51M | Buy |
+1,359,672
| New | +$51M | 0.01% | 1155 |
|